Extensive Analysis of Drugs for Schistosomiasis Market 2025: Global Players Bayer, CBC Pharma & VHB Life Science

Schistosomiasis is a chronic and acute disease, which is caused by parasitic trematode worms of the genus Schistosoma. This parasite is transmitted to human body when people consume infested water that contains larval forms of the parasite. Hence, this disease is mainly witnessed among people who regularly work in agricultural, domestic, occupational, and recreational sectors (that expose them to infested water). Since past few years, the prevalence of schistosomiasis is increasing continuously.

This is evident from the estimates of WHO, which states that at least 218 million people required preventive treatment for schistosomiasis in 2015. Moreover, up till 2017, schistosomiasis transmission has been reported from 78 countries. Such high prevalence of the disease clearly showcases the need for effective treatment drugs that prevent schistosomiasis occurrence. Currently, praziquantel drug is the recommended treatment against all forms of schistosomiasis.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2702

The factors that drive the growth of the global drugs for schistosomiasis market include rise in prevalence of schistosomiasis, lack of safe drinking water in developing countries, and inadequate healthcare facilities. However, high cost of drugs and stringent approval process restrains the market growth. Presence of large patient pool and unmet medical needs are anticipated to provide lucrative opportunities for the market growth.

MARKET PLAYERS:

• Bayer AG
• CBC Pharma.
• VHB Life Science Inc.
• Merck & Co. Inc.
• Taj Pharmaceuticals Ltd.
• V.H. Bhagat Pharmaceuticals Pvt. Ltd.
• Samarth Pharma Pvt. Ltd.

KEY BENEFITS OF DRUGS FOR SCHISTOSOMIASIS MARKET:

• In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2016 and 2023.

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global drugs for schistosomiasis market.

• Comprehensive analysis of factors that drive and restrict the growth of the global drugs for schistosomiasis market is provided.

• Key market players within the drugs for schistosomiasis market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2702

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.